Jillian Lau

SARS-CoV-2 seroprevalence in healthcare workers in a tertiary healthcare network in Victoria, Australia

Jillian Sy Lau, Paul Buntine, Melanie Price, Peteris Darzins, Evan Newnham, Ailie Connell, Roy Chean, Glenn Edwards, Stephen Guy

Journal article  |  2021  |  INFECTION DISEASE & HEALTH

BACKGROUND: Healthcare workers (HCW) are exposed to an increased risk of COVID-19 through direct contact with patients and patient..

The Impact of the COVID-19 Pandemic on People Living with HIV in Victoria, Australia

Mihiri Weerasuria, Christy Ko, Adam Ehm, Jessica O'Bryan, James McMahon, Ian Woolley, Jennifer Hoy, Jillian Lau

Journal article  |  2021  |  AIDS RESEARCH AND HUMAN RETROVIRUSES

As of January 12, 2021, Australia has reported 28,634 COVID-19 cases. Most (20,411) cases are from the state of Victoria. In respo..

A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls

James H McMahon, Jennifer M Zerbato, Jillian SY Lau, Jaclyn L Lange, Michael Roche, Carolin Tumpach, Ashanti Dantanarayana, Ajantha Rhodes, Judy Chang, Thomas A Rasmussen, Charlene A Mackenzie, Karen Alt, Michelle Hagenauer, Janine Roney, Jessica O'Bryan, Alexandra Carey, Richard McIntyre, Paul Beech, Graeme J O'Keefe, Christian W Wichmann, et al.

Journal article  |  2021  |  EBIOMEDICINE

BACKGROUND: A research priority in finding a cure for HIV is to establish methods to accurately locate and quantify where and how ..

Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings

Jillian SY Lau, Thomas A Rasmussen, Sharon R Lewin, Adam Ehm, Cipriano Martinez, Craig Burnett, James H McMahon

Journal article  |  2021  |  JOURNAL OF VIRUS ERADICATION

Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies

Jillian SY Lau, Miranda Z Smith, Brent Allan, Cipriano Martinez, Jennifer Power, Sharon R Lewin, James H McMahon

Journal article  |  2020  |  AIDS RESEARCH AND THERAPY

BACKGROUND: Analytical treatment interruptions (ATI) are commonly used clinical endpoints to assess interventions aimed at curing ..

Time for revolution? Enhancing meaningful involvement of people living with HIV and affected communities in HIV cure-focused science

Jillian SY Lau, Miranda Z Smith, Brent Allan, Karine Dube, A Toni Young, Jennifer Power

Journal article  |  2020  |  JOURNAL OF VIRUS ERADICATION

Introduction: Involving affected communities and people living with HIV (PLHIV) in HIV cure-focused clinical trials has ethical an..

An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial

James H McMahon, Jillian SY Lau, Janine Roney, Benjamin A Rogers, Jason Trubiano, Joseph Sasadeusz, James S Molton, Bradley Gardiner, Sue J Lee, Jennifer F Hoy, Allen Cheng, Anton Y Peleg

Journal article  |  2020  |  TRIALS

OBJECTIVES: Primary objective: To determine the efficacy of a candidate antiviral on time to virological cure compared to standard..

Perspectives on Analytical Treatment Interruptions in People Living with HIV and Their Health Care Providers in the Landscape of HIV Cure-Focused Studies

Jillian SY Lau, Miranda Z Smith, Brent Allan, Cipriano Martinez, Jennifer Power, Sharon R Lewin, James H McMahon

Journal article  |  2019  |  AIDS RESEARCH AND HUMAN RETROVIRUSES

Analytical treatment interruptions (ATIs) aim to assess effects of HIV cure-focused interventions, but poses potential risks. Unde..

Surveillance of life-long antibiotics-A cross-sectional cohort study assessing patient attitudes and understanding of long-term antibiotic consumption

Jillian SY Lau, Shivani Bhatt, Richard Streitberg, Mellissa Bryant, Tony M Korman, Ian Woolley

Journal article  |  2019  |  INFECTION DISEASE & HEALTH

BACKGROUND: Some patients receive long-term or life-long antibiotics for suppression of infections deemed otherwise incurable. Lit..

Reply to: 'Prevalence of HIV indicator conditions in late presenting patients with HIV: a missed opportunity for diagnosis?'

YD Lin, SE Garner, JSY Lau, TM Korman, IJ Woolley

Journal article  |  2019  |  QJM-AN INTERNATIONAL JOURNAL OF MEDICINE